Table-4.
Frequency (%) of the liver alteration severity index (I) after commercial formulation of atrazine exposure and recovery assays.
| Experiment | Group | 0-10 | 11-20 | 21-50 | >100 | I |
|---|---|---|---|---|---|---|
| Exposure | Control | 100 | - | - | - | 2.25±0.43 |
| Sublethal | 66.66 | 8.33 | - | 25 | 29.83±46.05* | |
| Nonlethal | 66.66 | 33.33 | - | - | 5.83±4.91 | |
| Control | 100 | - | - | - | 2.17±0.37 | |
| Recovery | Sublethal | 50 | 25 | - | 25 | 29.83±42.06* |
| Nonlethal | 75 | 25 | - | - | 4.74±4.21 |
I of 0-10=Normal functioning; I of 11-20=Light to moderate damage; I of 21-50=Moderate to severe alterations; I >100=Irreparable damage. n=12 fingerlings/experimental group. Data of I are expressed as means±SD.
*
p<0.05 (One-way analysis of variance followed by Bonferroni’s post-test)